Sotera Health Company (SHC)
NASDAQ: SHC · Services-Misc Health & Allied Services, NEC · Broadview Heights, OH
Our rating: Cautious
Call changed from Neutral to Cautious at $16.39, moderate conviction, November 4, 2026.
Breaks if: The Cautious call would be wrong if reported free-cash-flow margin climbs above 15% for two consecutive quarters — FCF margin currently sits near 12.4%, so the bar is reachable but not yet cleared, and reaching it would signal real earnings-power recovery that starts to justify the multiple. Separately, if the stock falls to around $12 within the next twelve months, the FCF yield rises to roughly 4.5% and the risk/reward framework changes materially enough to revisit the call. Neither condition is true today.
Key figures
| Market value | $4.5B |
|---|---|
| Revenue, last 12 months | $1.2B |
| Net income, last 12 months | $173M |
| Free cash flow, last 12 months | $135M |
| Price to earnings | 26.2× |
| Free cash flow yield | 3.0% |
| Dividend yield | 0.0% |
| Operating margin | n/a |
| Return on equity | 27.0% |
| Beta to the S&P 500 | 1.00 |
| Volatility, annualized | 37.6% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $325M | 4.4% | $0.20 | $58M |
| June 30, 2026 | $321M | 9.2% | $0.19 | $42M |
| March 31, 2026 | $280M | 10.0% | $0.09 | −$17M |
| December 31, 2025 | $303M | 4.6% | $0.12 | $52M |
| September 30, 2025 | $311M | 9.1% | $0.17 | $35M |
| June 30, 2025 | $294M | 6.4% | $0.03 | $26M |
| March 31, 2025 | $255M | 2.6% | $-0.05 | $36M |
| December 31, 2024 | $290M | −6.5% | $0.05 | −$10M |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $0.32B: Claude 62%, Gemini 85%, Mistral 70%
- Diluted earnings per share are at least $0.12: Claude 55%, Gemini 90%, Mistral 82%
- Free cash flow for the quarter is at least $0.05B: Claude 48%, Gemini 75%, Mistral 58%
11 ledger entries and 29 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.